NIH-funded research R01 grant

Investigating how a specific enzyme affects blood vessel function and organ injury during heart surgery

Official title: The effects of soluble guanylyl cyclase stimulation on perioperative vascular reactivity and organ injury in cardiac surgery trial

Funded at Vanderbilt University Medical Center · NIH-10917127 · Data updated 2026-11-12

This study is looking at how a specific enzyme affects blood vessel function and can lead to problems like kidney and brain injuries during heart surgery, with the goal of finding ways to help patients recover better and stay healthier after their procedures.

More Cardiac Surgery research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2024
Award (this year)$448,407
NIH project number5R01HL164909-03
Project IDNIH-10917127 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients scheduled for cardiac surgery who may be at risk for acute kidney or brain injuries.

Less likely to help

Patients who are not undergoing cardiac surgery or those with pre-existing severe organ dysfunction may not benefit from this research.

What this research studies

This research focuses on understanding the role of soluble guanylyl cyclase in regulating blood vessel function and its impact on organ injuries, particularly acute kidney and brain injuries, during cardiac surgery. The study aims to explore how disruptions in vascular reactivity can lead to complications such as delirium and longer hospital stays for patients. By examining the mechanisms behind these injuries, the research seeks to identify potential therapeutic targets that could improve patient outcomes. Patients undergoing cardiac surgery may be monitored for changes in vascular function and organ health throughout the surgical process.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing organ injuries during cardiac surgery, ultimately enhancing recovery and reducing complications for patients.

How similar studies have gone: Previous research has indicated that targeting vascular reactivity can lead to improved outcomes in similar patient populations, suggesting a promising avenue for this investigation.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Lopez, Marcos G — Vanderbilt University Medical Center
  • Study coordinator: Lopez, Marcos G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.